La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

AddLife Gestion

Gestion contrôle des critères 2/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Fredrik Dalborg

Directeur général

SEK 6.0m

Rémunération totale

Pourcentage du salaire du PDG	31.6%
Durée du mandat du directeur général	2yrs
Propriété du PDG	0.02%
Durée moyenne d'occupation des postes de direction	less than a year
Durée moyenne du mandat des membres du conseil d'administration	8.3yrs

Mises à jour récentes de la gestion

Recent updates

Analyse de la rémunération des PDG

Comment la rémunération de Fredrik Dalborg a-t-elle évolué par rapport aux bénéfices de AddLife?
Date	Rémunération totale	Salaire	Bénéfices de l'entreprise
Sep 30 2023	n/a	n/a	SEK 292m
Jun 30 2023	n/a	n/a	SEK 387m
Mar 31 2023	n/a	n/a	SEK 429m
Dec 31 2022	SEK 6m	SEK 2m	SEK 480m

Rémunération vs marché: La rémunération totale de Fredrik ($USD 591.46K ) est inférieure à la moyenne des entreprises de taille similaire sur le marché UK ($USD 2.14M ).

Rémunération et revenus: Données insuffisantes pour comparer la rémunération de Fredrik avec les performances de l'entreprise.

PDG

Fredrik Dalborg (51 yo)

2yrs

Titularisation

SEK 5,991,000

Compensation

Mr. Fredrik Dalborg serves as President & Chief Executive Officer at AddLife AB (publ) since 2022. Mr. Dalborg served as Managing Director for North America at Xvivo Perfusion AB (publ) since December 15,...

Équipe de direction

Nom	Position	Titularisation	Compensation	Propriété
Fredrik Dalborg	President & CEO	2yrs	SEK 5.99m	0.018% SEK 2.3m
Christina Rubenhag	Chief Financial Officer	2yrs	pas de données	0.0029% SEK 382.6k
Peter Simonsbacka	Chief Commercial Officer	less than a year	pas de données	0.060% SEK 8.0m
Christian Karlsson	Head of Business Development	3yrs	pas de données	pas de données
Per Wahlstedt	Head of Business Control	2yrs	pas de données	pas de données
Timmy Rosendal	Head of Sustainability	less than a year	pas de données	pas de données
Ioana Dragan	Head of Financial Control	less than a year	pas de données	pas de données
Jamilah Wass	Group Financial Controller	no data	pas de données	pas de données
Nichlas Essner	Group Business Controller	less than a year	pas de données	pas de données
Malin Lindh	Group Business Controller	less than a year	pas de données	pas de données

0.8yrs

Durée moyenne de l'emploi

53yo

Âge moyen

Gestion expérimentée: L'équipe de direction de ALIFBS n'est pas considérée comme expérimentée (ancienneté moyenne 0.8 ans), ce qui suggère une nouvelle équipe.

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Birgit Norinder	Independent Director	8.3yrs	SEK 350.00k	0.010% SEK 1.4m
Eva Elmstedt	Independent Director	2.7yrs	SEK 350.00k	0.0025% SEK 327.9k
Johan Sjo	Independent Chairman	8.8yrs	SEK 700.00k	0.14% SEK 18.1m
Håkan Roos	Independent Director	8.5yrs	SEK 350.00k	4.5% SEK 600.1m
Eva Nilsagard	Independent Director	8.1yrs	SEK 430.00k	0.0046% SEK 609.2k
Stefan Hedelius	Independent Director	8.3yrs	SEK 350.00k	0.024% SEK 3.2m

8.3yrs

Durée moyenne de l'emploi

61yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de ALIFBS sont considérés comme expérimentés (ancienneté moyenne 8.3 ans).

AddLife Gestion

Gestion contrôle des critères 2/4

Informations clés

Mises à jour récentes de la gestion

AddLife AB (publ), Annual General Meeting, May 08, 2024

Independent Director recently bought kr12m worth of stock

President & CEO recently bought kr129k worth of stock

President & CEO recently bought kr139k worth of stock

President & CEO recently bought kr112k worth of stock

President & CEO recently bought kr285k worth of stock

Recent updates

AddLife AB (publ) to Report Q1, 2025 Results on Apr 25, 2025

AddLife AB (publ) Approves Dividend, Payable on 16 May 2024

AddLife AB (publ) to Report Fiscal Year 2024 Results on Feb 05, 2025

AddLife AB (publ) to Report Fiscal Year 2023 Results on Apr 05, 2024

AddLife AB (publ) to Report Q3, 2024 Results on Oct 23, 2024

AddLife AB (publ) to Report First Half, 2024 Results on Jul 15, 2024

AddLife AB (publ), Annual General Meeting, May 08, 2024

Second quarter 2023 earnings released: EPS: kr0.27 (vs kr0.61 in 2Q 2022)

Independent Director recently bought kr12m worth of stock

Investor sentiment improves as stock rises 37%

President & CEO recently bought kr129k worth of stock

Addlife AB (Publ) Declares Dividend

Upcoming dividend of kr1.20 per share at 1.0% yield

President & CEO recently bought kr139k worth of stock

President & CEO recently bought kr112k worth of stock

AddLife AB (publ) Proposes Dividend for the Year Ended December 31, 2022

President & CEO recently bought kr285k worth of stock

Håkan Roos acquired a 0.246285% stake in AddLife AB (publ) for SEK 30 million.

AddLife AB (publ) to Report First Half, 2023 Results on Jul 14, 2023

AddLife AB (publ) to Report Q1, 2023 Results on Apr 26, 2023

Second quarter 2022 earnings released

Now 23% undervalued after recent price drop

Investor sentiment deteriorated over the past week

CFO & Business Area Manager of Medtech recently sold kr8.5m worth of stock

Addlife AB (Publ) Approves Dividend, Payable on 12 May 2022

AddLife AB (publ) Appoints Fredrik Dalborg as President

Full year 2021 earnings released: EPS: kr6.02 (vs kr4.62 in FY 2020)

AddLife AB (publ) (OM: ALIF B) acquired O'Flynn Medical Limited.

Addlife AB (Publ) Proposes Dividend, Payable on 12 May 2022

Investor sentiment improved over the past week

AddLife AB (publ) (OM:ALIF B) completed the acqusitions of Telia Health Monitoring.

President & CEO recently bought kr5.8m worth of stock

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Addlife AB (Publ) Proposes Dividend

Addlife AB (Publ) Announces Step Down of Kristina Willgård as Chief Executive Officer

AddLife AB (publ) (OM:ALIF B) completed the acquisition of MBA Incorporado S.A from Alantra Private Equity.

Investor sentiment deteriorated over the past week

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire MBA Incorporado S.A from Alantra Private Equity for approximately €110 million.

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire Telia Health Monitoring.

Beijing AddLife AB (publ) (OM:ALIF B) acquired Camanio AB from Brighter AB (publ) (OM:BRIG) for SEK 65 million.

President & CEO recently sold kr32m worth of stock

Third quarter 2021 earnings released

Investor sentiment deteriorated over the past week

Independent Chairman recently sold kr11m worth of stock

AddLife AB (publ) (OM:ALIF B) acquired Bio-Connect BV.

Investor sentiment improved over the past week

Chief Financial Officer recently sold kr106k worth of stock

Independent Chairman recently sold kr7.0m worth of stock

Second quarter 2021 earnings released: EPS kr1.46 (vs kr1.07 in 2Q 2020)

Investor sentiment improved over the past week

Chief Financial Officer recently sold kr14m worth of stock

Independent Director has left the company

AddLife AB (publ) Approves Dividend, Payable on 12 May 2021

First quarter 2021 earnings released

Upcoming dividend of kr1.50 per share

AddLife AB (Publ) Provides Earnings Guidance for 2021

New 90-day high: kr175

Full year 2020 earnings released: EPS kr4.62 (vs kr1.27 in FY 2019)

New 90-day high: kr169

AddLife AB (publ) to Report Fiscal Year 2021 Results on Feb 03, 2022

New 90-day high: kr150

Insider recently bought kr692k worth of stock

AddLife AB (publ) (OM:ALIF B) completed the acquisition of the advanced surgery business of SIAD Healthcare S.p.A.

AddLife AB (publ) to Report Nine Months, 2021 Results on Oct 22, 2021

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire Zafe Care Systems Ab.

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire Ropox A/S.

Analyse de la rémunération des PDG

PDG

Titularisation